Journal of Skin Cancer Case Reports (JSCCR) is a peer-reviewed, Open Access journal that publishes Case Reports on all aspects of skin cancer. We are especially interested in receiving manuscripts centred on the fields of Basal cell carcinoma (BCC), Squamous cell carcinoma of the skin (SCC), Melanoma, Nonmelanoma skin cancer (NMSC) and its rare forms such as Merkel cell carcinoma (MCC) or cutaneous sarcoma, cutaneous lymphoma.
Journal of Skin Cancer Case Reports encourages the submission of case reports focussed on screening, prevention, early detection including dermatoscopy, diagnosis, diagnostic procedures, pathology and treatment of all kind of skin malignancies. Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and molecular levels of the disease.
JSCCR discussing skin cancer prevention and detection in primary care by describing the main risk factors and prevention advice. We summarise key guidance on the symptoms and signs of skin cancers and their management, including their initial assessment and referral. In addition, we review emerging technologies and diagnostic aids which may become available for use in primary care in the near future, to aid the triage of suspicious skin lesions.
Journal also focuses on the topics that includes dermatofibrosarcoma protuberans, Kaposi's sarcoma, Merkel cell carcinoma, keratoacanthoma, sebaceous carcinomas, spindle cell tumors, microcystic adnexal carcinoma, Paget's disease of the breast, atypical fibroxanthoma, leiomyosarcoma, porocarcinoma and angiosarcoma. Journal publishes image articles, case reports and case series (series of 2 to 6 cases) related to the topics of skin cancer.
Please visit the Instructions page (https://www.salfordpublishers.org/jsccr/instructions-for-authors.html) for Article Preparation Guidelines, Process of Publication, Article Processing Charges (APC), Patient Consent and Confidentiality etc.
According to the American Cancer Society, skin cancer is the most common cancer of all cancer types. Although melanoma represents only about 1% of all skin cancers, this tumour is still responsible for most skin cancer deaths and its incidence is steadily on the rise. Skin cancers, basal and squamous cell carcinomas, malignant melanomas, and Merkel cell carcinomas, constitute arguably the most common and increasingly prevalent human neoplasms. Skincancer provides information on a wide range of skincancer topics with emphasis on the emergence of new diagnostic approaches, therapeutic perspectives, and a better insight into the biology of the skin tumours.
This journal entitled Journal of Skin Cancer Case Reports represents an International effort to highlight advances in our understanding of malignant melanoma from both clinical and research perspectives. Case reports in skin cancer journal publishes unique perspectives regarding melanoma epidemiology, risk factors, diagnostic and prognostic tools, phenotypes, treatment, and future research directions. Management of melanoma is challenging, especially for the late stage of the disease. Development of new therapies and optimizing current treatments are being pursued in attempt to further improve the survival rate.
Journal of Skin Cancer Case Reports provides up-to-date knowledge and experience in early diagnosis, prevention and treatment of melanoma as well as current ongoing clinical studies on melanoma. The journal also provides the most recent perspectives of research on the molecular basis of melanoma, such as melanoma associated genes and a possible link between stress and melanoma. It also includes several case reports that illustrate novel methods for diagnosing melanoma in the clinic using new technologies, which are likely to significantly improve outcomes. Several articles of this journal covers surgical techniques and other present very rare or challenging clinical cases of melanoma and how these were treated.
Skin Cancer Case Reports Journal provides an excellent overview of how melanoma is treated in the clinic. Since oncologists and clinicians across the globe contributed to this skin cancer journal, each area also explores the unique burdens that geographical areas experience from melanoma subtypes and how these are treated in different settings. Skin Cancer Case Reports Journal publishing articles by a diverse panel of experts, presents a description of the most relevant aspects of the epidemiology, diagnosis, local treatment, prognostic biomarkers and treatment for advanced disease, including the most recent research on novel molecules.